SecBot SecBot
EFFECT ·Filed Sep 2, 2026

FBRX

Forte Biosciences, Inc.
BEARISH
Impact 7/10
Horizondays Processed2mo ago SEC9999999995-26-002850
Actionable Insight ▼ Bearish

Expect a capital raise announcement within weeks as cash burn continues. The effectiveness of four separate shelves signals preparation for multiple or large offerings. Traders should watch for a prospectus supplement or 424B filing detailing the specific terms, any overnight offering at a discount would be a near-term negative catalyst.

DirectionBearish
Confidencehigh
Horizondays

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Forte Biosciences had four shelf registration statements (File Nos. 333-296425, 333-283814, 333-274257, 333-224880) declared effective by the SEC on September 1, 2026. These EFFECT notices clear the way for the company to conduct offerings under each shelf, including the $500M universal shelf filed in June 2026. For a clinical-stage biopharma burning ~$22M/quarter with $58.2M cash, this makes near-term capital raising highly probable, creating a significant dilution overhang that outweighs any positive pipeline developments.

Key Facts

  • Four shelf registration statements (File Nos. 333-296425, 333-283814, 333-274257, 333-224880) declared effective on September 1, 2026.
  • The $500M universal shelf (File No. 333-296425) was previously filed on June 6, 2026 and is now effective.
  • Forte is a clinical-stage biopharma with no revenue, burning ~$22M/quarter, and had $58.2M cash as of March 31, 2026.
  • The shelf represents massive potential dilution relative to the company's market cap, enabling the company to sell common stock, preferred stock, debt, and warrants.

Financial Impact

Up to $500M in securities can now be offered, representing substantial dilution relative to the company's market cap

dilutioncash

Risk Factors

  • Imminent dilutive offering likely given cash burn trajectory
  • Potential for multiple offerings from separate shelf registrations
  • No revenue to offset dilution, all funding must come from equity or debt markets

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
55% bullish (11 analysts)

Investment Themes

Documents Analyzed

This report is based on 12 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (FBRX), Batch item 19999999995-26-002850
Document: 9999999995-26-002850-index.html9999999995-26-002847
Document: 9999999995-26-002850.txt9999999995-26-002846
EFFECT Filing (FBRX), Batch item 49999999995-26-002847
Document: 9999999995-26-002847-index.html9999999995-26-002850
Document: 9999999995-26-002847.txt9999999995-26-002850
EFFECT Filing (FBRX), Batch item 79999999995-26-002846
Document: 9999999995-26-002846-index.html9999999995-26-002850
Document: 9999999995-26-002846.txt9999999995-26-002850
EFFECT Filing (FBRX), Batch item 109999999995-26-002843
Document: 9999999995-26-002843-index.html9999999995-26-002850
Document: 9999999995-26-002843.txt9999999995-26-002850

Track record

15 reports on FBRX

Performance horizon

2 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +39.79% at T+60 after the Apr 8, 2026 report. 4 of 7 went positive at some point.

Filters
  1. Nov 13, 20263d ago SC 13G/A Bearish 5/10 Entry price pending
  2. Nov 13, 20263d ago SC 13G/A Bearish 5/10 Entry price pending
  3. Nov 4, 202612d ago SC 13G/A Bearish 4/10 No price data
  4. Sep 2, 202610w ago EFFECT Bearish 7/10 Viewing Entry $76.99 settles Nov 27
  5. Sep 2, 202610w ago EFFECT Bearish 6/10 Entry $76.99 settles Nov 27
  6. Aug 27, 202611w ago 25-NSE Bearish 9/10 Entry $76.99 settles Nov 20
  7. Jul 27, 202616w ago 8-K Bullish 8/10 Entry $76.50 No price data
  8. Jun 11, 202622w ago EFFECT Bearish 6/10 Entry $17.40 No price data
  9. Jun 5, 202623w ago S-3/A Bearish 6/10 Entry $15.67 No price data
  10. Jun 2, 202623w ago S-3 Bearish 6/10 Entry $17.00 to $76.99 ▼ −352.88% −350.38% vs SPY
Showing 10 of 15

US Market Status

Market Closed · Opens Wed (11h 56m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 2, 2026